HealthyNCT04264104
Effect of Nervous System Mobilization on Athletes' Performance
A study testing neural mobilization in people with Healthy, run by Aveiro University at 1 site in Portugal.
Trial summary
This study aims to compare the effects of two diferente doses of nervous system mobilization on athletes performance. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Healthy
- What is being tested?
- neural mobilization
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 52 participants
- Where
- 1 sitePortugal
- Study dates
- 28 Feb 2020to 15 Oct 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Healthy athletes
Who cannot join
- Nerve damage
- Arthritis
- Tumors
- Vascular conditions
- Spinal cord injuries
- Any sistemic condition
Show all 9Show fewer
- Surgery in the past 6 months
- Injury in the last 3 months
- A knee angle of <10º
Trial locations and contacts
1 site in 1 country.
About this study
This study aims to compare the effects of two diferente doses of nervous system mobilization on athletes performance.
Read the detailed description
It is anticipated that 60 athletes will be randomly allocated to receive either 4x10 (n=30) or 8x10 (n=30) repetitions of neural mobilization .
Data on flexibility (knee extension test) and lower limb strength and motor control (hop tests and vertical jump test) will be collected at baseline and after the neural mobilization.
Statistical analysis will be performed using a mixed-methods ANOVA.
- Conditions
- Healthy
- Being tested
- neural mobilization
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
neural mobilizationOther
This is a type of mobilization that uses a specific combination of joint movements
| Study group | Role | What they receive |
|---|---|---|
| Low dose neural mobilization | Experimental | Four series of 10 repetitions of neural mobilization targeting the tibial nerve. Receives: Other: neural mobilization |
| High dose neural mobilization | Active comparator | Eight series of 10 repetitions of neural mobilization targeting the tibial nerve. Receives: Other: neural mobilization |
What is being measured
The primary outcome is the main question the study is designed to answer.
Single Leg Hop Test
Participants are asked to perform one single unipedal jump and the jump width is measured.
Measured: Baseline
Single Leg Hop Test
Participants are asked to perform one single unipedal jump and the jump width is measured.
Measured: Up to 1 hour after baseline
Crossover Test
Participants are asked to jump as far as possible on a single leg three consecutive times, without losing balance and landing firmly. The total width of the 3 consecutive jumps is measured.
Measured: Baseline
Crossover Test
Participants are asked to jump as far as possible on a single leg three consecutive times, without losing balance and landing firmly. The total width of the 3 consecutive jumps is measured.
Measured: Up to 1 hour after baseline
Secondary outcomes (6)
6-meter Time Hop Test
The aim is to jump as fast as possible on a single leg over a distance of 6 meters, without losing balance and landing firmly. The time taken to perform this test is the measure of interest.
Measured: Baseline
6-meter Time Hop Test
The aim is to jump as fast as possible on a single leg over a distance of 6 meters, without losing balance and landing firmly. The time taken to perform this test is the measure of interest.
Measured: Up to 1 hour after baseline
Vertical Jump test
Participants are asked to jump upwards and the height jumped is measured.
Measured: Baseline
Vertical Jump test
Participants are asked to jump upwards and the height jumped is measured.
Measured: Up to 1 hour after baseline
Knee extension test
Participants are in a prone position, hip at 90º flexion and knee extension is performed. The measure of interest is the knee extension angle.
Measured: Baseline
Knee extension test
Participants are in a prone position, hip at 90º flexion and knee extension is performed. The measure of interest is the knee extension angle.
Measured: Up to 1 hour after baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Feb 2020
- Study start28 Feb 2020
- Primary completion28 Jul 2020
- Study completion15 Oct 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for HealthyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 52 participants (actual)
Sponsor and investigators
- Lead sponsor
- Aveiro University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Anabela G Silva, Aveiro University
- Investigators
- Anabela Silva, Principal investigator, Aveiro University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04264104
- Sponsor's protocol ID
- 13-CED/2019
- Status last verified
- Feb 2020
- First submitted
- 6 Feb 2020
- Last updated
- 4 Oct 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 Oct 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Nervous System Mobilization on Athletes' Performance
- ClinicalTrials.gov ID
- NCT04264104
- Acronym / sponsor ID
- 13-CED/2019
- Conditions
- Healthy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 52 participants (actual)
- Lead sponsor
- Aveiro UniversityUniversity, hospital or other
- Study start
- 28 Feb 2020 (actual)
- Primary completion
- 28 Jul 2020 (actual)
- Study completion
- 15 Oct 2020 (actual)
- First posted
- 11 Feb 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to compare the effects of two diferente doses of nervous system mobilization on athletes performance.
Detailed description
It is anticipated that 60 athletes will be randomly allocated to receive either 4x10 (n=30) or 8x10 (n=30) repetitions of neural mobilization .
Data on flexibility (knee extension test) and lower limb strength and motor control (hop tests and vertical jump test) will be collected at baseline and after the neural mobilization.
Statistical analysis will be performed using a mixed-methods ANOVA.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Low dose neural mobilization | Experimental | Other: neural mobilizationFour series of 10 repetitions of neural mobilization targeting the tibial nerve. |
| High dose neural mobilization | Active comparator | Other: neural mobilizationEight series of 10 repetitions of neural mobilization targeting the tibial nerve. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Healthy athletes
Key exclusion criteria (9 listed)
- Nerve damage
- Arthritis
- Tumors
- Vascular conditions
- Spinal cord injuries
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| neural mobilizationThis is a type of mobilization that uses a specific combination of joint movements | Other | High dose neural mobilization, Low dose neural mobilization |
Primary outcome
Single Leg Hop Test
Time frame: Baseline
Participants are asked to perform one single unipedal jump and the jump width is measured.
Single Leg Hop Test
Time frame: Up to 1 hour after baseline
Participants are asked to perform one single unipedal jump and the jump width is measured.
Crossover Test
Time frame: Baseline
Participants are asked to jump as far as possible on a single leg three consecutive times, without losing balance and landing firmly. The total width of the 3 consecutive jumps is measured.
Crossover Test
Time frame: Up to 1 hour after baseline
Participants are asked to jump as far as possible on a single leg three consecutive times, without losing balance and landing firmly. The total width of the 3 consecutive jumps is measured.
6 secondary outcomes
6-meter Time Hop Test
Time frame: Baseline
6-meter Time Hop Test
Time frame: Up to 1 hour after baseline
Vertical Jump test
Time frame: Baseline
Vertical Jump test
Time frame: Up to 1 hour after baseline
Knee extension test
Time frame: Baseline
Knee extension test
Time frame: Up to 1 hour after baseline
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Oct 2021.
- Individual participant dataSharing planned: No
Related trials for Healthy
Recruiting
Trained vs. Untrained: Lower Extremity Pressure Changes
Trained Athletes, Untrained
Not yet recruitingPhase 1
Comparison of Pharmacokinetic/Pharmacodynamic Characteristics and Safety of GZR101-80 Injection With Separately Injected, Simultaneous Doses of GZR33 Injection and Insulin Aspart
Healthy Participants
Active, not recruitingPhase 2
Effect of Equol Supplementation on Arterial Stiffness and Cognition in Healthy Volunteers
Arterial Stiffness, White Matter Lesions
Enrolling by invitationObservational study
Screening for Hematology Branch Protocols
Hematologic Disease and Disorders, Donors
RecruitingPhase 1
A Study of Single and Multiple Subcutaneous or Intravenous Doses of ADX-001 in Healthy Adults to Assess Safety, Effects, and Immune Response
Healthy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Anabela Silva principal investigator
Aveiro University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing neural mobilization in people with Healthy, run by Aveiro University at 1 site in Portugal.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Single Leg Hop Test (time frame: Baseline). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Oct 2021; AzTrials last refreshed its copy on 6 Nov 2026.